Septic shock from descending necrotizing mediastinitis - Combined treatment with IgM-enriched immunoglobulin preparation and direct polymyxin B hemoperfusion: A case report

被引:6
|
作者
Pota V. [1 ]
Passavanti M.B. [1 ]
Sansone P. [1 ]
Pace M.C. [1 ]
Peluso F. [1 ]
Fiorelli A. [2 ]
Aurilio C. [1 ]
机构
[1] Department of Women, Infant and Surgical and Specialist Surgery, University of Campania L. Vanvitelli, Piazza Miraglia 2, Naples
[2] Thoracic Surgery Unit, University of Campania L. Vanvitelli, Naples
关键词
IgM-enriched immunoglobulin preparation; Mediastinitis; Polymyxin B hemoperfusion; Septic shock;
D O I
10.1186/s13256-018-1611-5
中图分类号
学科分类号
摘要
Background: Descending necrotizing mediastinitis is a common and progressive polymicrobial infection involving the neck and chest with a high death rate (10 to 40%). From a microbiological point of view, descending necrotizing mediastinitis is sustained by Gram-positive bacteria (43-62%), anaerobes (46-78%), and, rarely, Gram-negative bacteria. Data collected during the Antibiotic Resistance-Istituto Superiore di Sanità project confirmed that Italy is positioned among the countries with the highest levels of resistance in most pathogenic species under surveillance. In particular, 32.9% of Klebsiella pneumoniae isolates were resistant to carbapenem, 33.6% of Staphylococcus aureus to methicillin, and 28.7% and 43.9% of Escherichia coli isolates to third-generation cephalosporins and fluoroquinolones, respectively. Case presentation: We describe the case of a 38-year-old white man with septic shock due to descending necrotizing mediastinitis sustained by multidrug-resistant Gram-negative and Gram-positive bacteria treated after surgery with an IgM-enriched immunoglobulin preparation and polymyxin B hemoperfusion therapy. Conclusion: Despite the contrasting data on the use of immunoglobulins and polymyxin B hemoperfusion in septic shock and the lack of literature in cases of acute mediastinitis caused by both Gram-negative and Gram-positive multidrug-resistant bacteria, we obtained an improvement in clinical conditions and the survival of our patient, against all odds. © 2018 The Author(s).
引用
收藏
相关论文
共 18 条
  • [1] The Role of the Intravenous IgA and IgM-Enriched Immunoglobulin Preparation in the Treatment of Sepsis and Septic Shock
    Berlot, Giorgio
    Zanchi, Silvia
    Moro, Edoardo
    Tomasini, Ariella
    Bixio, Mattia
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (14)
  • [2] Successful treatment of septic shock with disseminated intravascular coagulation using combined polymyxin-B direct hemoperfusion and recombinant thrombomodulin therapy
    Matsuki, Yasunari
    Matsuki, Yuka
    Shigemi, Kenji
    ANAESTHESIA PAIN & INTENSIVE CARE, 2016, 20 (04) : 462 - 464
  • [3] IgM-enriched immunoglobulin treatment for septic shock: We should put in balance outcome and serious side effects before giving this therapy!
    Honore, Patrick M.
    Redant, Sebastien
    Preseau, Thierry
    Moorthamers, Sofie
    Kaefer, Keitiane
    Gutierrez, Leonel Barreto
    Attou, Rachid
    Gallerani, Andrea
    De Bels, David
    JOURNAL OF CRITICAL CARE, 2021, 65 : 235 - 236
  • [4] THE DURATION FROM RECOGNITION OF SHOCK TO THE INDUCTION OF THE DIRECT HEMOPERFUSION OF POLYMYXIN B-IMMOBILIZED FIBER CRITICALLY DETERMINES THE SURVIVAL OF PATIENT WITH SEPTIC SHOCK
    Funahashi, Yoshio
    Oishi, Hideto
    Maruyama, Shoichi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [5] Clinical Effects and Outcomes After Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Treatment for Septic Shock in Preterm Neonates*
    Nishizaki, Naoto
    Hara, Taichi
    Obinata, Kaoru
    Nakagawa, Mayu
    Shimizu, Toshiaki
    PEDIATRIC CRITICAL CARE MEDICINE, 2020, 21 (02) : 156 - 163
  • [6] Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial)
    Biagioni, Emanuela
    Tosi, Martina
    Berlot, Giorgio
    Castiglione, Giacomo
    Corona, Alberto
    De Cristofaro, Maria Giovanna
    Donati, Abele
    Feltracco, Paolo
    Forfori, Francesco
    Fragranza, Fiorentino
    Murino, Patrizia
    Piazza, Ornella
    Tullo, Livio
    Grasselli, Giacomo
    D'Amico, Roberto
    Girardis, Massimo
    BMJ OPEN, 2021, 11 (02):
  • [7] Could There Be a Biologically Plausible Niche for Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Treatment in Early Onset Neonatal Septic Shock?*
    Aldewereld, Zachary
    Carcillo, Joseph A.
    PEDIATRIC CRITICAL CARE MEDICINE, 2020, 21 (02) : 202 - 203
  • [8] Septic shock due to Escherichia coli meningoencephalitis treated with immunoglobulin-M-enriched immunoglobulin preparation as adjuvant therapy: a case report
    Pota, V
    Passavanti, M. B.
    Coppolino, F.
    Di Zazzo, F.
    De Nardis, L.
    Esposito, R.
    Fiore, M.
    di Santostefano, G. S. R. C. Mangoni
    Aurilio, C.
    Sansone, P.
    Pace, M. C.
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [9] Septic shock due to Escherichia coli meningoencephalitis treated with immunoglobulin-M-enriched immunoglobulin preparation as adjuvant therapy: a case report
    V. Pota
    M. B. Passavanti
    F. Coppolino
    F. Di Zazzo
    L. De Nardis
    R. Esposito
    M. Fiore
    G. S. R. C. Mangoni di Santostefano
    C. Aurilio
    P. Sansone
    M. C. Pace
    Journal of Medical Case Reports, 15
  • [10] Effect of direct hemoperfusion with a polymyxin B immobilized fiber column on high mobility group box-1 (HMGB-1) in severe septic shock: Report of a case
    Department of Emergency and Critical Care Medicine, Chiba Hokisou Hospital, Nippon Medical School, Chiba, Japan
    不详
    不详
    ASAIO J., 2006, 6 (e37-e39):